The surgical infection control device market has witnessed major growth over the past five years and is expected to continue this momentum into the future, growing at a compound annual growth rate (CAGR) of 6.6%, the market is expected to hit a value of $84 billion by 2017.
Growth within the surgical infection control device market is set to be driven by the increased focus on the prevention, diagnosis, and treatment of diseases requiring surgical procedures, advancements in anesthetics, and an increasing aging population.
A number of challenges still remain for the surgical infection control device market to face including, a wide variation in awareness and adoption rates, a decline in capital expenditure of hospitals, lack of trained and qualified manpower, and socioeconomic diversity in population and healthcare infrastructure.
The surgical infection control device market is made up of a variety of products and instruments including, safety syringes, injection needles, surgical endoscopes, wound dressing materials, stereotactic surgical devices, surgical gloves and apparel, and surgical lights.
The US currently dominates the surgical infection control device market and is expected to continue this through to 2017, however, although APAC is currently a small market the growing middle class in Asia, especially China, India, and Southeast Asia presents excellent growth potential.
For more information on the surgical infection control device market, see the latest research: Surgical Infection Control Device Market Report
Follow us on Twitter @CandMResearch
Companiesandmarkets.com issues news updates and report summaries covering all major industries and sectors. The service provides additional client monitoring and timely alerts to breaking industry and sector news leading the day's business headlines. News articles, written by our staff, contain additional analyst insight, providing value added insight for our readers. News updates and real-time alerts on newly-released market reports are also available from our Facebook page, Twitter feed @CandMResearch and RSS links. We also welcome inquiries from business journalists and the news media.